221 related articles for article (PubMed ID: 34699973)
1. Precision diagnostics in lymphomas - Recent developments and future directions.
Mansouri L; Thorvaldsdottir B; Laidou S; Stamatopoulos K; Rosenquist R
Semin Cancer Biol; 2022 Sep; 84():170-183. PubMed ID: 34699973
[TBL] [Abstract][Full Text] [Related]
2. Clinical impact of recurrently mutated genes on lymphoma diagnostics: state-of-the-art and beyond.
Rosenquist R; Rosenwald A; Du MQ; Gaidano G; Groenen P; Wotherspoon A; Ghia P; Gaulard P; Campo E; Stamatopoulos K;
Haematologica; 2016 Sep; 101(9):1002-9. PubMed ID: 27582569
[TBL] [Abstract][Full Text] [Related]
3. A genetic profiling guideline to support diagnosis and clinical management of lymphomas.
Sánchez-Beato M; Méndez M; Guirado M; Pedrosa L; Sequero S; Yanguas-Casás N; de la Cruz-Merino L; Gálvez L; Llanos M; García JF; Provencio M
Clin Transl Oncol; 2024 May; 26(5):1043-1062. PubMed ID: 37672206
[TBL] [Abstract][Full Text] [Related]
4. Novel precision medicine approaches and treatment strategies in hematological malignancies.
Rosenquist R; Bernard E; Erkers T; Scott DW; Itzykson R; Rousselot P; Soulier J; Hutchings M; Östling P; Cavelier L; Fioretos T; Smedby KE
J Intern Med; 2023 Oct; 294(4):413-436. PubMed ID: 37424223
[TBL] [Abstract][Full Text] [Related]
5. Genomic stratification for the treatment of lymphomas.
Dave SS
Hematology Am Soc Hematol Educ Program; 2013; 2013():331-4. PubMed ID: 24319200
[TBL] [Abstract][Full Text] [Related]
6. Learning from the failures of drug discovery in B-cell non-Hodgkin lymphomas and perspectives for the future: chronic lymphocytic leukemia and diffuse large B-cell lymphoma as two ends of a spectrum in drug development.
Kubuschok B; Trepel M
Expert Opin Drug Discov; 2017 Jul; 12(7):733-745. PubMed ID: 28494631
[TBL] [Abstract][Full Text] [Related]
7. Genetic landscape and deregulated pathways in B-cell lymphoid malignancies.
Rosenquist R; Beà S; Du MQ; Nadel B; Pan-Hammarström Q
J Intern Med; 2017 Nov; 282(5):371-394. PubMed ID: 28631441
[TBL] [Abstract][Full Text] [Related]
8. Recurrent Cytogenetic Abnormalities in Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia.
Ma ES
Methods Mol Biol; 2017; 1541():279-293. PubMed ID: 27910030
[TBL] [Abstract][Full Text] [Related]
9. Towards precision medicine in lymphoid malignancies.
Bühler MM; Martin-Subero JI; Pan-Hammarström Q; Campo E; Rosenquist R
J Intern Med; 2022 Aug; 292(2):221-242. PubMed ID: 34875132
[TBL] [Abstract][Full Text] [Related]
10. Molecular Subgroups of Diffuse Large B Cell Lymphoma: Biology and Implications for Clinical Practice.
Weber T; Schmitz R
Curr Oncol Rep; 2022 Jan; 24(1):13-21. PubMed ID: 35060000
[TBL] [Abstract][Full Text] [Related]
11. Next generation sequencing in routine diagnostics of mature non-Hodgkin's B-cell lymphomas.
Breinholt MF; Schejbel L; Gang AO; Nielsen TH; Pedersen LM; Høgdall E; Nørgaard P
Eur J Haematol; 2023 Oct; 111(4):583-591. PubMed ID: 37452559
[TBL] [Abstract][Full Text] [Related]
12. Precision diagnostics in chronic lymphocytic leukemia: Past, present and future.
Mollstedt J; Mansouri L; Rosenquist R
Front Oncol; 2023; 13():1146486. PubMed ID: 37035166
[TBL] [Abstract][Full Text] [Related]
13. Clinical prognostic biomarkers in chronic lymphocytic leukemia and diffuse large B-cell lymphoma.
Chastain EC; Duncavage EJ
Arch Pathol Lab Med; 2015 May; 139(5):602-7. PubMed ID: 25248094
[TBL] [Abstract][Full Text] [Related]
14. Genomic signatures in B-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?
Iqbal J; Naushad H; Bi C; Yu J; Bouska A; Rohr J; Chao W; Fu K; Chan WC; Vose JM
Blood Rev; 2016 Mar; 30(2):73-88. PubMed ID: 26432520
[TBL] [Abstract][Full Text] [Related]
15. [The genetic landscape of chronic lymphocytic leukemia].
Marosvári D; Alpár D; Király AP; Rajnai H; Reiniger L; Bödör C
Magy Onkol; 2016 Jun; 60(2):118-25. PubMed ID: 27275638
[TBL] [Abstract][Full Text] [Related]
16. Clinical Applications of the Genomic Landscape of Aggressive Non-Hodgkin Lymphoma.
Moffitt AB; Dave SS
J Clin Oncol; 2017 Mar; 35(9):955-962. PubMed ID: 28297626
[TBL] [Abstract][Full Text] [Related]
17. Predictive and prognostic molecular biomarkers in lymphomas.
Iorgulescu JB; Medeiros LJ; Patel KP
Pathology; 2024 Mar; 56(2):239-258. PubMed ID: 38216400
[TBL] [Abstract][Full Text] [Related]
18. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
19. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
[TBL] [Abstract][Full Text] [Related]
20. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
